Literature DB >> 7408409

Interaction between diflunisal and warfarin.

M J Serlin, S Mossman, R G Sibeon, K F Tempero, A M Breckenridge.   

Abstract

The effect of diflunisal on steady-state warfarin dynamics and kinetics was studied in five healthy men taking daily subtherapeutic doses of warfarin. Diflunisal 500 mg twice daily for 2 wk increased the percentage unbound warfarin from 1.02% to 1.24% and lowered total warfarin from 741 to 533 ng/ml, but did not alter the anticoagulant response (prothrombin complex activity, PCA). When diflunisal was discontinued but warfarin continued, there was a loss of anticoagulant effect and a difference in the rates at which percentage unbound warfarin and total warfarin concentration returned to prediflunisal levels. There was a correlation between plasma diflunisal and percentage unbound warfarin. Diflunisal reduced both the maximum plasma protein-binding capacity for warfarin and the apparent association constant.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408409     DOI: 10.1038/clpt.1980.193

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  14 in total

Review 1.  Protein binding drug displacement interactions fact or fiction?

Authors:  J J MacKichan
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

Review 2.  What is the true clinical significance of plasma protein binding displacement interactions?

Authors:  L N Sansom; A M Evans
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 3.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

4.  Inter-relationship among individual vitamin K-dependent clotting factors at different levels of anticoagulation.

Authors:  E Chan; L Aarons; M Serlin; A Breckenridge; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

Review 5.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

6.  Combining NSAIDs with anticoagulants: yes and no.

Authors:  J W O'Callaghan; R N Thompson; A S Russell
Journal:  Can Med Assoc J       Date:  1984-10-15       Impact factor: 8.262

Review 7.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 8.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 9.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 10.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.